Standout Papers

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-contr... 2017 2026 2020 2023 576
  1. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2017)
    Dilan Athauda, Kate Maclagan et al. The Lancet
  2. Structures of α-synuclein filaments from human brains with Lewy pathology (2022)
    Yang Yang, Yue‐De Yang et al. Nature
  3. Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease (2019)
    Eduardo De Pablo‐Fernández, Andrew J. Lees et al. JAMA Neurology

Immediate Impact

1 by Nobel laureates 19 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Medical, surgical, and physical treatments for Parkinson's disease
2024 Standout
The epidemiology of Parkinson's disease
2024 Standout
8 intermediate papers

Works of Thomas T. Warner being referenced

Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update
2022
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
2017 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Thomas T. Warner 4512 3401 3609 298 12.7k
Thomas N. Chase 10194 12818 1490 386 27.3k
Barbro B. Johansson 2013 2533 470 242 10.1k
Emmanuel Mignot 644 1615 2532 364 20.3k
Gary W. Miller 4108 5630 313 253 18.1k
V. Cuomo 242 3545 711 336 12.1k
Colin Green 297 936 795 298 14.1k
Zuzana Walker 2599 864 1119 217 9.5k
Robert Dunn 306 3148 879 174 9.4k
Bruno Weber 574 2574 497 221 9.9k
Ian A. Simpson 615 1975 838 259 15.8k

All Works

Loading papers...

Rankless by CCL
2026